Showing 951-960 of 2689 results for "".
Poststroke Care
https://practicalneurology.com/diseases-diagnoses/stroke/poststroke-care/30147/Stroke outcomes can be optimized with an evidenced-based and systematic approach during all phases of recovery.Sleep & Neurodegenerative Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/sleep--neurodegenerative-disease/30108/Sleep problems are common and treatable in neurodegenerative disorders, and may also be a treatable risk factor and early biomarker.Novel Treatments for Alzheimer Disease Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/novel-treatments-for-alzheimer-disease-disorders/31801/A selection of drugs currently in clinical trials organized by Common Alzheimer Disease Research Ontology focused on mechanisms of action.Neurotoxin Therapy: A Closer Look at the Four Options
https://practicalneurology.com/columns/practice-management/neurotoxin-therapy-a-closer-look-at-the-four-options/30818/The field of neurotoxins has grown recently, but how do the agents compare? Here's a closer look at the therapies available on the US market.Pharmacologic Considerations in the Treatment of Older Adults With Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pharmacologic-considerations-in-the-treatment-of-older-adults-with-epilepsy/32176/Many antiseizure medications are available for treatment of older adults with epilepsy, and choosing the best option requires understanding of their pharmacokinetic and pharmacodynamic properties.Imaging Outcome Measures in Neuromuscular Diseases
https://practicalneurology.com/diseases-diagnoses/neuromuscular/imaging-outcome-measures-in-neuromuscular-diseases/35584/MRI is an important tool for assessing muscle and nerve changes in neuromuscular disease and is helpful to clinicians in monitoring therapeutic outcomes.Autoimmune Movement Disorders in Adults
https://practicalneurology.com/diseases-diagnoses/movement-disorders/autoimmune-movement-disorders-in-adults/31702/As antibodies to neuronal targets are described, we see the clinical spectrum and pathophysiology of autoimmune movement disorders more clearly.Stroke Spotlight: Subarachnoid Hemorrhage and Cerebral Vasospasm
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-spotlight-subarachnoid-hemorrhage-and-cerebral-vasospasm/31524/Cerebral vasospasm increases morbidity and mortality in persons with subarachnoid hemorrhage.Managing Symptoms of Depression, Apathy, Psychosis, and Agitation in People Living with Alzheimer Disease
https://practicalneurology.com/archives/aug-2025-issue/managing-symptoms-of-depression-apathy-psychosis-and-agitation-in-people-living-with-alzheimer-disease/36689/Optimal treatment of neuropsychiatric symptoms in Alzheimer disease necessitates early identification, rigorous clinical differentiation, and the development of individualized therapeutic approaches.Comorbidity Disparities in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/comorbidity-disparities-in-multiple-sclerosis/31763/Comorbid diseases that are often more prevalent in underserved groups have large effects on multiple sclerosis prognosis.